eXoZymes (NASDAQ:EXOZ – Get Free Report) and CAMP4 Therapeutics (NASDAQ:CAMP – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings and analyst recommendations.
Profitability
This table compares eXoZymes and CAMP4 Therapeutics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| eXoZymes | N/A | -220.63% | -141.26% |
| CAMP4 Therapeutics | -2,193.72% | -194.74% | -95.64% |
Earnings & Valuation
This table compares eXoZymes and CAMP4 Therapeutics”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| eXoZymes | $70,000.00 | 1,150.86 | -$9.16 million | ($1.14) | -8.33 |
| CAMP4 Therapeutics | $3.50 million | 63.50 | -$80.40 million | ($2.36) | -1.81 |
eXoZymes has higher earnings, but lower revenue than CAMP4 Therapeutics. eXoZymes is trading at a lower price-to-earnings ratio than CAMP4 Therapeutics, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent ratings and recommmendations for eXoZymes and CAMP4 Therapeutics, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| eXoZymes | 1 | 0 | 0 | 0 | 1.00 |
| CAMP4 Therapeutics | 1 | 1 | 5 | 0 | 2.57 |
CAMP4 Therapeutics has a consensus price target of $8.60, indicating a potential upside of 100.93%. Given CAMP4 Therapeutics’ stronger consensus rating and higher probable upside, analysts plainly believe CAMP4 Therapeutics is more favorable than eXoZymes.
Volatility and Risk
eXoZymes has a beta of 2.85, suggesting that its share price is 185% more volatile than the S&P 500. Comparatively, CAMP4 Therapeutics has a beta of 0.04, suggesting that its share price is 96% less volatile than the S&P 500.
Summary
CAMP4 Therapeutics beats eXoZymes on 7 of the 12 factors compared between the two stocks.
About eXoZymes
eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
About CAMP4 Therapeutics
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location. The company also offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and advanced telematics products for the broader connected vehicle and Internet of Things marketplace, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. In addition, it offers professional services, including project management, engineering services, and installation services. The company sells its products and services to customers in the automotive, telecommunications, industrial equipment, transportation and logistics, government and municipalities, insurance, original equipment manufacturers, and leasing companies. It markets through direct sales organization, channel partner program, original equipment manufacturers, and independent sales representatives and distributors, as well as its websites and digital platform. The company was incorporated in 1981 and is headquartered in Irvine, California.
Receive News & Ratings for eXoZymes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eXoZymes and related companies with MarketBeat.com's FREE daily email newsletter.
